Geode Capital Management LLC Buys 10,421 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Geode Capital Management LLC grew its position in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 0.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,089,398 shares of the company's stock after buying an additional 10,421 shares during the period. Geode Capital Management LLC owned 2.41% of HealthEquity worth $200,522,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in HQY. Pier Capital LLC bought a new position in shares of HealthEquity in the fourth quarter worth $8,024,000. HighTower Advisors LLC boosted its stake in HealthEquity by 4.8% in the 4th quarter. HighTower Advisors LLC now owns 95,075 shares of the company's stock worth $9,122,000 after purchasing an additional 4,370 shares during the period. Geneva Capital Management LLC grew its holdings in HealthEquity by 24.6% during the 4th quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company's stock valued at $100,642,000 after buying an additional 206,894 shares in the last quarter. BNP Paribas Financial Markets increased its position in shares of HealthEquity by 165.7% during the third quarter. BNP Paribas Financial Markets now owns 20,437 shares of the company's stock valued at $1,673,000 after buying an additional 12,745 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of HealthEquity by 2.4% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,086,811 shares of the company's stock valued at $104,280,000 after acquiring an additional 25,004 shares during the period. Institutional investors own 99.55% of the company's stock.

Remove Ads

HealthEquity Trading Up 2.8 %

Shares of HQY stock traded up $2.26 on Friday, hitting $82.20. 926,462 shares of the company's stock traded hands, compared to its average volume of 759,548. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The stock has a market capitalization of $7.11 billion, a price-to-earnings ratio of 75.41, a P/E/G ratio of 1.60 and a beta of 0.49. The company's fifty day simple moving average is $97.63 and its 200 day simple moving average is $96.30. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59.

Insider Activity

In related news, EVP Michael Henry Fiore sold 8,881 shares of the firm's stock in a transaction dated Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the sale, the executive vice president now directly owns 56,655 shares of the company's stock, valued at $4,433,820.30. This trade represents a 13.55 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now directly owns 78,219 shares of the company's stock, valued at $8,704,992.51. The trade was a 6.85 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 20,381 shares of company stock valued at $1,781,432. 2.20% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

HQY has been the subject of several analyst reports. The Goldman Sachs Group cut their price target on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a report on Thursday, March 27th. Wells Fargo & Company boosted their target price on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. Barrington Research reaffirmed an "outperform" rating and issued a $112.00 price target on shares of HealthEquity in a report on Friday. KeyCorp cut their price objective on HealthEquity from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Monday, March 24th. Finally, Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and lowered their target price for the company from $120.00 to $115.00 in a research note on Tuesday, March 25th. One research analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, HealthEquity has an average rating of "Buy" and an average target price of $112.58.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.